Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
Clinical trial NCT02926456 · COMPLETED
Trial details
- NCT number
- NCT02926456
- Sponsor
- Janssen-Cilag S.p.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-22
- Primary completion
- 2018-02-14
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.